Results 241 to 250 of about 111,076 (331)

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models. [PDF]

Sci Rep
Orozco Morales ML, Lansley SM, Chin WL, Tilsed CM, Principe N, Leslie C, Vitali BJ, Rwandamuriye FX, de Jong E, Kidman J, Zemek RM, Rinaldi CA, Lassmann T, Bosco A, Lee YCG, Lake RA, Chee J, Lesterhuis WJ.   +17 more
europepmc   +1 more source

MesoRet: a reticulin stain-based deep learning algorithm to assist diffuse mesothelioma subtyping. [PDF]

Pathologica
Orlando G, Ferrero AP, Impalà GA, Pittaro A, Delsedime L, Pedrosa R, Kumar D, Righi L, Pelosi G, Papotti MG, Duregon E.   +10 more
europepmc   +1 more source

Hydrogen Peroxide Promotes Epithelial to Mesenchymal Transition and Stemness in Human Malignant Mesothelioma Cells

, 2013
Myung‐Chul Kim, Feng‐Ji Cui, Yongbaek Kim   +2 more
openalex   +2 more sources

Regional immunosuppression and associated systemic markers in focally relapsed sarcomatoid mesothelioma: case report. [PDF]

J Immunother Cancer
Ollila H, Kulkarni P, Kim H, Ankola P, Chintala NK, Thomas C, Sauter JL, Offin M, Adusumilli PS.   +8 more
europepmc   +1 more source

Supplementary Figure S3 from Low Exposures to Amphibole or Serpentine Asbestos in Germline <i>Bap1</i>-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment

Yuwaraj Kadariya, Eleonora Sementino, Maggie Ruan, Mitchell Cheung, Parham Hadikhani, Hatice U. Osmanbeyoglu, Andres J. Klein–Szanto, Kathy Q. Cai, Joseph R. Testa   +8 more
openalex   +1 more source

Dynamic evaluation of the glycolytic determinants LDH-A and GLUT-1 enhances prognostic significance and their inhibition affects the growth of mesothelioma spheroids. [PDF]

Mol Metab
Franczak MA, Borea F, Donati V, Aliprandi M, Avan A, Doldi V, Bononi G, Tam KY, Granchi C, Smolenski RT, Zucali PA, Minutolo F, Peters GJ, Giovannetti E.   +13 more
europepmc   +1 more source

Burden of Ovarian Cancer in China Attributable to Asbestos Exposure During 1990-2021 and the Projections Through 2050. [PDF]

Int J Womens Health
Jin D, Hua L, Huang Q, Lei R, Xu C, Chen X, Chen P, Chen T.   +7 more
europepmc   +1 more source

Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers. [PDF]

Curr Oncol
Bondì G, Martella S, Stylianakis D, Terminella A, Lococo F, Ciarrocchi A, Fiorelli A, Cusumano G.   +7 more
europepmc   +1 more source

Case report: Onychopapilloma in a patient with BAP1 tumor predisposition syndrome-a useful clinical marker? [PDF]

Fam Cancer
Sjøstrøm E, Ahlborn LB, Eliesen EV, Wadt K, Lei U, Byrjalsen A.   +5 more
europepmc   +1 more source

A Phase I Trial of Repeated Intrapleural Adenoviral-mediated Interferon-β Gene Transfer for Mesothelioma and Metastatic Pleural Effusions

, 2010
Daniel H. Sterman, Adri Recio, Andrew R. Haas, Anil Vachani, Sharyn I. Katz, Colin T. Gillespie, Guanjun Cheng, Jing Sun, Edmund K. Moon, Luana Pereira, Xinzhong Wang, Daniel F. Heitjan, Leslie A. Litzky, Carl H. June, Robert H. Vonderheide, Richard G. Carroll, Steven Μ. Albelda   +16 more
openalex   +1 more source